The Use of Positron-Emission Tomography–Magnetic Resonance Imaging to Improve the Local Staging of Disease in Myxofibrosarcoma: A Feasibility Study
<b>Background/Objectives</b>: Myxofibrosarcomas (MFSs) are aggressive soft-tissue sarcomas (STSs) that often arise in the upper and lower limbs. MFSs are a highly infiltrative sarcoma subtype with a high positive margin rate and poor clinical outcomes. Their management involves multidisciplinary team (MDT) input, with the mainstay of treatment being a wide surgical resection to remove the whole tumour, but this can be challenging due to the infiltrative nature of MFSs through fascial planes. Appropriate pre-operative imaging is therefore essential for surgical planning. Currently, MRI imaging is the modality of choice to assess the soft-tissue extent of MFSs; however, it does not always reliably predict tumour extent, especially when an MRI shows high-signal curvilinear projections, known as "tails", which often represent tumour extension and increase the risk of positive margins and local recurrence. <b>Methods</b>: This feasibility study therefore aimed to investigate whether the addition of an FDG PET-MRI and DWI MRI is superior for the local staging of MFSs compared to a standard MRI, and to assess its practicality for clinical use. <b>Results</b>: Of the eight patients recruited, six completed the required scans, proceeded to surgery, and were included in the data analyses. Five of the six patients had close (<2 mm) or positive margins requiring re-excision. <b>Conclusions</b>: Our results show that combining an FDG-PET and DWI MRI may offer a more accurate local staging of MFSs than a conventional MRI; however, a larger prospective trial is needed to further investigate this pilot data. Nevertheless, this novel feasibly study demonstrates the potential use of PET-MRI and DWI for improving pre-operative planning prior to the surgical resection of MFSs.
Authors
- Thomas B. Beckingsale
- Simon Lowes (ORCID: https://orcid.org/0000-0003-1959-266X)
- Michael John Firbank (ORCID: https://orcid.org/0000-0002-9536-0185)
- Philip Sloan (ORCID: https://orcid.org/0000-0002-0142-0213)
- Elizabeth Howell (ORCID: https://orcid.org/0000-0001-6957-8714)
- Geoff Hide (ORCID: https://orcid.org/0000-0002-3608-0175)
- George Petrides (ORCID: https://orcid.org/0000-0001-8734-4049)
- John Tuckett
- Maniram Ragbir (ORCID: https://orcid.org/0000-0002-1041-3752)
- Craig Gerrand (ORCID: https://orcid.org/0000-0003-3043-4507)
- Corey D. Chan (ORCID: https://orcid.org/0000-0003-3339-8791)
- Petra Dildey
- Kenneth S. Rankin (ORCID: https://orcid.org/0000-0001-6302-0269)
- R. Pearson (ORCID: https://orcid.org/0000-0002-7822-5037)
- Marcus J. Brookes (ORCID: https://orcid.org/0000-0001-5871-6720)
- Tamir Ali
- Raj Sinha (ORCID: https://orcid.org/0009-0000-0714-6027)
Institutions
- Newcastle upon Tyne Hospitals NHS Foundation Trust (GB)
- Freeman Hospital (GB)
- Royal National Orthopaedic Hospital (GB)
- North Cumbria Integrated Care NHS Foundation Trust (GB)
- Gateshead Health NHS Foundation Trust (GB)
- Royal National Orthopaedic Hospital NHS Trust (GB)
- University College London (GB)
- Newcastle University (GB)
Publication Details
- Journal
- Diagnostics
- Published
- 2025-04-19
- DOI
- https://doi.org/10.3390/diagnostics15081039
- Primary Topic
- Sarcoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00